Sophia Genetics Sa (SOPH)

$4.40 -0.07 (-1.57%)
Market Cap 297.35M
Revenue (ttm) 65.17M
Net Income (ttm) -62.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -95.89%
Debt to Equity Ratio 0.62
Volume 73,200
Avg Vol 78,622
Day's Range N/A - N/A
Shares Out 67.58M
Stochastic %K 67%
Beta 1.10
Analysts Strong Sell
Price Target $7.00

Company Profile

SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switze...

Industry: Health Information Services
Sector: Healthcare
Phone: 41 21 694 10 60
Address:
La PiEce 12, Rolle, Switzerland
Parnell8
Parnell8 Oct. 1 at 3:16 PM
$TEM $SOPH benefits from AI + kids even more bc levered to research vs clinical
0 · Reply
highnihilism
highnihilism Oct. 1 at 10:37 AM
$NWG Natwest Group Trades: 18 | Total $: 3.4 K | 90D Avg: 30.6 K | Rel. Notional: 0.11 | Call $: 1.4 K | Put $: 2 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $SOPH Sophia Genetics Trades: 6 | Total $: 1.8 K | 90D Avg: 843 | Rel. Notional: 2.19 | Call $: 1.4 K | Put $: 420 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $NHC National Healthcare Trades: 3 | Total $: 1.4 K | 90D Avg: 2.8 K | Rel. Notional: 0.51 | Call $: 1.4 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $LGND Ligand Pharmaceuticals Trades: 6 | Total $: 5.5 K | 90D Avg: 17.2 K | Rel. Notional: 0.32 | Call $: 1.4 K | Put $: 4.1 K | % Single-Leg: 50% | % Multi-Leg: 50% | % Contingent: –
0 · Reply
StockScanners
StockScanners Oct. 1 at 2:04 AM
$SOPH reached 4.90
0 · Reply
StockScanners
StockScanners Sep. 30 at 1:28 AM
$SOPH reached 4.50
0 · Reply
Bulltrader988
Bulltrader988 Sep. 29 at 6:31 PM
$SOPH breakout confirmed... 52W High $ 4.92 ... Lets break it 👃👀 https://finviz.com/quote.ashx?t=SOPH&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Sep. 29 at 6:18 PM
$SOPH new support building for next leg up 👃👀
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 5:39 AM
$SOPH Excellent article that nails exactly where SOPH stands right now. So if you want to update your SOPH knowledge or get acquainted with SOPH, this is a must read. https://beyondspx.com/quote/SOPH/analysis/sophia-genetics-ai-driven-growth-ignites-precision-medicine-expansion-nasdaq-soph
0 · Reply
SadyK189
SadyK189 Sep. 29 at 1:35 AM
Top Stocks to watch next week 2 / 2: $APDN $SOPH $DFLI $PRLD $STKH APDN: Getting up on 4hours chart. Key support at 3.40 - 3.70. Currently at 4.49. Next key level to test lies at 5.20 - 5.60 PRLD: Looking good on daily chart. Key support at 1.15 - 1.30. Next key lest to test 1.90 - 2.05. Currently at 1.53 DFLI: Still looking good on 4hours chart. Key support at 0.38 - 0.41. It can test 0.55 - 0.5850 zone again. Currently at 0.46 STKH: Good close of 4hours candle. 4.15 - 4.45 is acting as key support zone. Next key level to test is 6.75 - 7.15. Currently at 5.83 SOPH: Getting up on daily chart. Key support at 3.20 - 3.50. Next key level to test is 4.8 - 5.15. It may take sometime though. Currently at 4.13
0 · Reply
Bulltrader988
Bulltrader988 Sep. 28 at 8:51 PM
$SOPH wonderful chart 👃👀 https://finviz.com/quote.ashx?t=SOPH&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Sep. 28 at 8:24 PM
$SOPH 👃👀 https://x.com/JNacsnson/status/1972395169996771526?t=fpjQ39I_71n17PGCAOHNpw&s=19
0 · Reply
Latest News on SOPH
Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025, 8:01 AM EDT - 11 days ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

Sep 23, 2025, 8:00 AM EDT - 11 days ago

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion Diagnostic Offering in Liquid Biopsy

MYGN

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

Sep 22, 2025, 8:00 AM EDT - 12 days ago

SOPHiA GENETICS Expands Collaboration with AstraZeneca to Enhance Detection of Breast and Prostate Cancer

AZN

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

Sep 5, 2025, 4:00 AM EDT - 4 weeks ago

SOPHiA GENETICS and Jessa Ziekenhuis Announce Precision Oncology Partnership from the European Congress of Pathology

SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 11:19 PM EDT - 2 months ago

SOPHiA GENETICS SA (SOPH) Q2 2025 Earnings Call Transcript

SOPHiA GENETICS Reports Second Quarter 2025 Results

Aug 5, 2025, 6:45 AM EDT - 2 months ago

SOPHiA GENETICS Reports Second Quarter 2025 Results

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

Aug 5, 2025, 6:40 AM EDT - 2 months ago

SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes

AZN

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

Jul 22, 2025, 8:00 AM EDT - 2 months ago

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2025 on August 5, 2025

SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call Transcript

May 10, 2025, 3:05 AM EDT - 5 months ago

SOPHiA GENETICS SA (SOPH) Q1 2025 Earnings Call Transcript

SOPHiA GENETICS Reports First Quarter 2025 Results

May 6, 2025, 6:45 AM EDT - 5 months ago

SOPHiA GENETICS Reports First Quarter 2025 Results

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

Apr 28, 2025, 12:00 PM EDT - 5 months ago

SOPHiA GENETICS Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR

AZN

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Apr 22, 2025, 8:00 AM EDT - 5 months ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2025 on May 6, 2025

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

Apr 8, 2025, 2:00 AM EDT - 6 months ago

Precision for Medicine Partners with SOPHiA GENETICS to Expand Biopharma Services with the SOPHiA DDM™ Platform and its Liquid Biopsy Capabilities

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

Mar 18, 2025, 9:00 AM EDT - 7 months ago

SOPHiA GENETICS Announces Two Million Patient Cases Analyzed, Marking a New Milestone for Data-Driven Medicine at NVIDIA GTC

SOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call Transcript

Mar 4, 2025, 2:32 PM EST - 7 months ago

SOPHiA GENETICS SA (SOPH) Q4 2024 Earnings Call Transcript

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Mar 4, 2025, 6:45 AM EST - 7 months ago

SOPHiA GENETICS Reports Fourth Quarter and Full Year 2024 Results

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

Feb 24, 2025, 4:00 AM EST - 7 months ago

Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing

AZN

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

Feb 18, 2025, 8:30 AM EST - 8 months ago

SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

Jan 28, 2025, 8:46 AM EST - 8 months ago

SOPHiA GENETICS Launches Comprehensive MRD Tracking Capabilities

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

Nov 21, 2024, 5:30 AM EST - 11 months ago

SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024

SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript

Nov 5, 2024, 2:46 PM EST - 11 months ago

SOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call Transcript

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

Nov 5, 2024, 6:32 AM EST - 11 months ago

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer

SOPHiA GENETICS Reports Third Quarter 2024 Results

Nov 5, 2024, 6:30 AM EST - 11 months ago

SOPHiA GENETICS Reports Third Quarter 2024 Results

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

Oct 22, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

Sep 14, 2024, 9:00 AM EDT - 1 year ago

SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

Sep 12, 2024, 7:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Poster Presentations at ESMO 2024

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

Sep 12, 2024, 4:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

Sep 10, 2024, 10:16 AM EDT - 1 year ago

SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing

AZN

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

Sep 5, 2024, 8:30 AM EDT - 1 year ago

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

Sep 4, 2024, 6:00 AM EDT - 1 year ago

SOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

Aug 28, 2024, 1:30 PM EDT - 1 year ago

SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

SOPHiA DDM™ Platform Certified Under IVDR

Aug 14, 2024, 3:00 AM EDT - 1 year ago

SOPHiA DDM™ Platform Certified Under IVDR

SOPHiA GENETICS Reports Second Quarter 2024 Results

Aug 6, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS Reports Second Quarter 2024 Results

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

Jul 29, 2024, 10:30 AM EDT - 1 year ago

SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 24, 2024, 11:59 AM EDT - 1 year ago

SOPHIA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

Jul 24, 2024, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

Jul 23, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for Second Quarter 2024 on August 6, 2024

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

Jul 4, 2024, 2:30 AM EDT - 1 year ago

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting

Jun 24, 2024, 9:47 AM EDT - 1 year ago

SOPHiA GENETICS Publishes Results of 2024 Annual General Meeting

SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

Jun 24, 2024, 2:00 AM EDT - 1 year ago

SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform

Jun 13, 2024, 6:00 AM EDT - 1 year ago

SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

May 30, 2024, 12:19 PM EDT - 1 year ago

SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

May 29, 2024, 10:00 AM EDT - 1 year ago

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

SOPHiA GENETICS Announces Instituto Mário Penna as New Customer

May 20, 2024, 10:02 AM EDT - 1 year ago

SOPHiA GENETICS Announces Instituto Mário Penna as New Customer

Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS

May 16, 2024, 6:02 AM EDT - 1 year ago

Klinikum Klagenfurt am Wörthersee is Live with SOPHiA GENETICS

SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript

May 12, 2024, 2:46 AM EDT - 1 year ago

SOPHiA GENETICS SA (SOPH) Q1 2024 Earnings Call Transcript

SOPHiA GENETICS Reports First Quarter 2024 Results

May 7, 2024, 6:45 AM EDT - 1 year ago

SOPHiA GENETICS Reports First Quarter 2024 Results

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Apr 30, 2024, 7:05 AM EDT - 1 year ago

SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

Apr 23, 2024, 10:29 AM EDT - 1 year ago

SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

Apr 23, 2024, 5:05 AM EDT - 1 year ago

SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa

Parnell8
Parnell8 Oct. 1 at 3:16 PM
$TEM $SOPH benefits from AI + kids even more bc levered to research vs clinical
0 · Reply
highnihilism
highnihilism Oct. 1 at 10:37 AM
$NWG Natwest Group Trades: 18 | Total $: 3.4 K | 90D Avg: 30.6 K | Rel. Notional: 0.11 | Call $: 1.4 K | Put $: 2 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $SOPH Sophia Genetics Trades: 6 | Total $: 1.8 K | 90D Avg: 843 | Rel. Notional: 2.19 | Call $: 1.4 K | Put $: 420 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $NHC National Healthcare Trades: 3 | Total $: 1.4 K | 90D Avg: 2.8 K | Rel. Notional: 0.51 | Call $: 1.4 K | Put $: 0 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $LGND Ligand Pharmaceuticals Trades: 6 | Total $: 5.5 K | 90D Avg: 17.2 K | Rel. Notional: 0.32 | Call $: 1.4 K | Put $: 4.1 K | % Single-Leg: 50% | % Multi-Leg: 50% | % Contingent: –
0 · Reply
StockScanners
StockScanners Oct. 1 at 2:04 AM
$SOPH reached 4.90
0 · Reply
StockScanners
StockScanners Sep. 30 at 1:28 AM
$SOPH reached 4.50
0 · Reply
Bulltrader988
Bulltrader988 Sep. 29 at 6:31 PM
$SOPH breakout confirmed... 52W High $ 4.92 ... Lets break it 👃👀 https://finviz.com/quote.ashx?t=SOPH&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Sep. 29 at 6:18 PM
$SOPH new support building for next leg up 👃👀
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 29 at 5:39 AM
$SOPH Excellent article that nails exactly where SOPH stands right now. So if you want to update your SOPH knowledge or get acquainted with SOPH, this is a must read. https://beyondspx.com/quote/SOPH/analysis/sophia-genetics-ai-driven-growth-ignites-precision-medicine-expansion-nasdaq-soph
0 · Reply
SadyK189
SadyK189 Sep. 29 at 1:35 AM
Top Stocks to watch next week 2 / 2: $APDN $SOPH $DFLI $PRLD $STKH APDN: Getting up on 4hours chart. Key support at 3.40 - 3.70. Currently at 4.49. Next key level to test lies at 5.20 - 5.60 PRLD: Looking good on daily chart. Key support at 1.15 - 1.30. Next key lest to test 1.90 - 2.05. Currently at 1.53 DFLI: Still looking good on 4hours chart. Key support at 0.38 - 0.41. It can test 0.55 - 0.5850 zone again. Currently at 0.46 STKH: Good close of 4hours candle. 4.15 - 4.45 is acting as key support zone. Next key level to test is 6.75 - 7.15. Currently at 5.83 SOPH: Getting up on daily chart. Key support at 3.20 - 3.50. Next key level to test is 4.8 - 5.15. It may take sometime though. Currently at 4.13
0 · Reply
Bulltrader988
Bulltrader988 Sep. 28 at 8:51 PM
$SOPH wonderful chart 👃👀 https://finviz.com/quote.ashx?t=SOPH&ty=c&ta=1&p=d
0 · Reply
Bulltrader988
Bulltrader988 Sep. 28 at 8:24 PM
$SOPH 👃👀 https://x.com/JNacsnson/status/1972395169996771526?t=fpjQ39I_71n17PGCAOHNpw&s=19
0 · Reply
StockScanners
StockScanners Sep. 27 at 4:17 AM
$SOPH keep watch if this holds above 3.75
0 · Reply
Bulltrader988
Bulltrader988 Sep. 26 at 7:36 PM
$SOPH ....👃👀
0 · Reply
PeakedSeller
PeakedSeller Sep. 23 at 2:52 PM
$MYGN $MYGN x $SOPH = global liquid-biopsy CDx build (MSK-ACCESS). Strategic win (US regs + 800-site ex-US network), but no $$ today—so fade. Hold $7.5, push >$8.05, and $8.8–$9.2 stays on deck into Q3.
0 · Reply
Bulltrader988
Bulltrader988 Sep. 22 at 8:07 PM
$SOPH 👋👋 👃👀
0 · Reply
Bulltrader988
Bulltrader988 Sep. 22 at 6:40 PM
$SOPH 🤝🤝 $AZN
0 · Reply
kairilara
kairilara Sep. 22 at 5:53 PM
$SOPH NXXT snagged prime FL land for AI cloud hubs. 200MW microgrid coming online. Microcap vibes to multibagger 🌴⚡️🚀
0 · Reply
Bulltrader988
Bulltrader988 Sep. 22 at 12:19 PM
$SOPH 🤝🤝 $AZN 👃👀 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-expands-collaboration-with-astra-zeneca-to-enhance-ehr041nvcza2.html
0 · Reply
Bulltrader988
Bulltrader988 Sep. 8 at 6:23 PM
$SOPH ...still pounding... 👃👀
0 · Reply
dcrown
dcrown Sep. 6 at 2:17 PM
$SOPH
0 · Reply
Bulltrader988
Bulltrader988 Sep. 5 at 10:34 AM
$SOPH 👃👀 https://www.stocktitan.net/news/SOPH/sop-hi-a-genetics-and-jessa-ziekenhuis-announce-precision-oncology-xxfrjy3x6zgt.html
0 · Reply
Bulltrader988
Bulltrader988 Aug. 22 at 6:10 PM
$SOPH ...still pounding the table here 👃👀
0 · Reply
phishphan
phishphan Aug. 21 at 3:26 PM
$SOPH bought 100 shares yesterday, gonna try and load another 400 more thru rest of this year for longer hold.
0 · Reply